Alpine Immune Sciences Ownership | Who Owns Alpine Immune Sciences?
Alpine Immune Sciences Ownership Summary
Alpine Immune Sciences is owned by 100.87% institutional investors. Capula management is the largest institutional shareholder, holding 0% of ALPN shares. NT R2000 Growth Index Fund - NL is the top mutual fund, with 0.07% of its assets in Alpine Immune Sciences shares.
ALPN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Alpine Immune Sciences | 100.87% | - | -0.87% |
Sector | Healthcare Stocks | 46.98% | 7.90% | 45.12% |
Industry | Biotech Stocks | 44.85% | 7.67% | 47.48% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Capula management | - | - | - |
Highpoint advisor group | - | - | - |
First trust advisors lp | - | - | - |
Woodline partners lp | - | - | - |
Scientech research | - | - | - |
Price t rowe associates inc /md/ | - | - | - |
Darwin global management | - | - | - |
Geode capital management | - | - | - |
Voya investment management | - | - | - |
Algert global | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Capula management | - | - | - |
Highpoint advisor group | - | - | - |
First trust advisors lp | - | - | - |
Woodline partners lp | - | - | - |
Scientech research | - | - | - |
Price t rowe associates inc /md/ | - | - | - |
Darwin global management | - | - | - |
Geode capital management | - | - | - |
Voya investment management | - | - | - |
Algert global | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rothschild investment | - | - | -5.00 |
Nelson, van denburg & campbell wealth management group | - | - | -6.00 |
Principal securities | - | - | -6.00 |
Riggs asset managment | - | - | -16.00 |
Farther finance advisors | - | - | -20.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Decheng capital | - | - | -8.32M |
Avoro capital advisors | - | - | -5.78M |
Blackrock | - | - | -3.58M |
Frazier life sciences management | - | - | -3.13M |
Price t rowe associates inc /md/ | - | - | -3.08M |
Sold Out
Holder | Change |
---|---|
Rothschild investment | -5.00 |
Nelson, van denburg & campbell wealth management group | -6.00 |
Principal securities | -6.00 |
Riggs asset managment | -16.00 |
Farther finance advisors | -20.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2024 | 190 | 40.74% | 64,590,370 | 9.60% | 100 | 0.73% | 129 | 10.26% | 42 | 320.00% |
Dec 31, 2023 | 135 | 51.69% | 58,933,180 | 28.33% | 117 | 1.35% | 117 | 129.41% | 10 | -52.38% |
Sep 30, 2023 | 89 | 15.58% | 45,924,841 | 24.14% | 93 | 1.57% | 51 | -3.77% | 21 | 75.00% |
Jun 30, 2023 | 77 | 30.51% | 36,995,107 | 6.71% | 76 | 1.45% | 53 | 70.97% | 12 | -7.69% |
Mar 31, 2023 | 59 | -7.81% | 34,668,753 | 1.33% | 72 | 1.31% | 31 | -24.39% | 13 | 44.44% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
NT R2000 Growth Index Fund - NL | 50.66K | 0.07% | - |
NT R2000 Value Index Fund - NL | 43.88K | 0.06% | - |
The Vanguard Russell 2000 Growth Index | 32.45K | 0.05% | -137.00 |
Acuitas US Microcap Strategy | 31.90K | 0.05% | - |
Vanguard Instl Ttl Stck Mkt Idx Tr | 30.72K | 0.04% | 7.87K |
ProFunds Biotechnology UltraSector Inv | 22.42K | 0.03% | 13.89K |
SSgA U.S. Extended Market Index Class I | 19.00K | 0.03% | 8.30K |
TD Health Sciences - I | 16.60K | 0.02% | 16.60K |
Blackstone Alternative Multi-Strategy I | 10.70K | 0.02% | 6.90K |
Pictet TR - Div Alpha J EUR | 10.17K | 0.01% | 10.17K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | - | 1 |
2024 Q1 | - | 3 |
2023 Q4 | 2 | 29 |
2023 Q2 | - | - |
2023 Q1 | - | - |
ALPN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools